McCarson K E, Krause J E
Department of Anatomy and Neurobiology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Neuroscience. 1995 Feb;64(3):729-39. doi: 10.1016/0306-4522(94)00442-8.
Tachykinin peptides such as substance P and neurokinin B have been widely studied as mediators of pain transmission. The expression of neurokinin-1 and neurokinin-3 receptor messenger RNAs in the spinal cord is increased following intense nociception. The opiate ligands morphine and naltrexone alter behavioral responses to formalin-induced pain and alter evoked substance P release. This study investigated whether these opiates similarly alter the expression of substance P-, neurokinin B-, neurokinin-1 receptor- and neurokinin-3 receptor-encoding messenger RNAs in spinal systems following formalin-induced nociception. Expression levels of various messenger RNAs were quantitated using solution hybridization-nuclease protection assays. Six hours after hindpaw treatment, the levels of substance P-encoding preprotachykinin messenger RNA in the lumbar dorsal root ganglia and neurokinin B, neurokinin-1 receptor and neurokinin-3 receptor messenger RNAs in the lumbar dorsal horn were increased by approximately two-fold as compared to sham-treated controls. Pretreatment with naltrexone resulted in a further increase in the nociception-induced substance P messenger RNA expression in the dorsal root ganglia; preprotachykinin messenger RNA expression was not affected by morphine. Nociception-induced neurokinin-1 receptor messenger RNA expression in the dorsal horn was blocked by morphine, but was not affected by naltrexone. Both morphine and naltrexone blocked the formalin-induced increases in neurokinin B and neurokinin-3 receptor messenger RNA levels. Increased neurokinin B messenger RNA expression may reflect increased neurokinin B turnover in spinal interneurons activated by nociception. Neurokinin-3 receptor messenger RNA expression levels varied closely with, and thus may be regulated by, the levels of neurokinin B messenger RNA in the same regions. The results of this study indicate that pretreatment with opiate ligands modulates the expression of tachykinin peptide and neurokinin receptor encoding mRNAs in spinal systems following a peripheral chemogenic inflammatory stimulus. Thus, endogenous opioid systems may be involved in activity-induced changes in the expression of spinal tachykinin peptides and neurokinin receptors.
速激肽类物质,如P物质和神经激肽B,作为疼痛传递的介质已得到广泛研究。强烈伤害性刺激后,脊髓中神经激肽-1和神经激肽-3受体信使核糖核酸的表达增加。阿片类配体吗啡和纳曲酮可改变对福尔马林诱导疼痛的行为反应,并改变诱发的P物质释放。本研究调查了这些阿片类药物是否同样会改变福尔马林诱导伤害性刺激后脊髓系统中P物质、神经激肽B、神经激肽-1受体和神经激肽-3受体编码信使核糖核酸的表达。使用溶液杂交-核酸酶保护分析法对各种信使核糖核酸的表达水平进行定量。后爪处理6小时后,与假处理对照组相比,腰段背根神经节中P物质编码前速激肽信使核糖核酸以及腰段背角中神经激肽B、神经激肽-1受体和神经激肽-3受体信使核糖核酸的水平增加了约两倍。纳曲酮预处理导致背根神经节中伤害性刺激诱导的P物质信使核糖核酸表达进一步增加;前速激肽信使核糖核酸表达不受吗啡影响。伤害性刺激诱导的背角中神经激肽-1受体信使核糖核酸表达被吗啡阻断,但不受纳曲酮影响。吗啡和纳曲酮均阻断了福尔马林诱导的神经激肽B和神经激肽-3受体信使核糖核酸水平的增加。神经激肽B信使核糖核酸表达增加可能反映了伤害性刺激激活的脊髓中间神经元中神经激肽B周转增加。神经激肽-3受体信使核糖核酸表达水平与同一区域神经激肽B信使核糖核酸水平密切相关,因此可能受其调节。本研究结果表明,阿片类配体预处理可调节外周化学性炎症刺激后脊髓系统中速激肽肽和神经激肽受体编码信使核糖核酸的表达。因此,内源性阿片系统可能参与了脊髓速激肽肽和神经激肽受体表达的活性诱导变化。